Would lipophilic statin therapy as a prognostic factor improve survival in patients with uterine cervical cancer?
International Journal of Gynecological Cancer Sep 16, 2017
Song MK, et al. - The objective of this study is to examine whether statin therapy as a prognostic factor would significantly predict survival in cervical cancer. The outcome of this study suggests that the continuous lipophilic statin therapy from the prediagnostic period of uterine cervical cancer could reflect favorable outcome, independently in the present study.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries